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Genome-wide association analysis identifies common variants
influencing infant brain volumes
K Xia1, J Zhang2, M Ahn2,9, S Jha3, JJ Crowley1,4,5, J Szatkiewicz1,4, T Li6, F Zou2,10, H Zhu2,6, D Hibar7,11, P Thompson7,
ENIGMA Consortium, PF Sullivan1,4,8, M Styner1, JH Gilmore1 and RC Knickmeyer1
Genome-wide association studies (GWAS) of adolescents and adults are transforming our understanding of how genetic variants
impact brain structure and psychiatric risk, but cannot address the reality that psychiatric disorders are unfolding developmental
processes with origins in fetal life. To investigate how genetic variation impacts prenatal brain development, we conducted a GWAS
of global brain tissue volumes in 561 infants. An intronic single-nucleotide polymorphism (SNP) in IGFBP7 (rs114518130) achieved
genome-wide significance for gray matter volume (P= 4.15 × 10− 10). An intronic SNP in WWOX (rs10514437) neared genome-wide
significance for white matter volume (P= 1.56 × 10− 8). Additional loci with small P-values included psychiatric GWAS associations
and transcription factors expressed in developing brain. Genetic predisposition scores for schizophrenia and ASD, and the number
of genes impacted by rare copy number variants (CNV burden) did not predict global brain tissue volumes. Integration of these
results with large-scale neuroimaging GWAS in adolescents (PNC) and adults (ENIGMA2) suggests minimal overlap between
common variants impacting brain volumes at different ages. Ultimately, by identifying genes contributing to adverse
developmental phenotypes, it may be possible to adjust adverse trajectories, preventing or ameliorating psychiatric and
developmental disorders.
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INTRODUCTION
Advances in genomics are providing new insights into the biology
of psychiatric disorders.1 At the same time, advances in magnetic
resonance imaging (MRI) are transforming our understanding of
the structural and functional organization of the human brain.2
Classic twin studies, as well as genome-wide association studies
(GWAS), show that the structure of the human brain is strongly
shaped by genetics.3,4 Altered brain structure has been reported in
individuals with psychiatric disorders5 and in asymptomatic
individuals with a family history,6 suggesting that genetic
influences on disease risk are partly mediated by changes in
neuroanatomy. It is thus somewhat surprising that large-scale
imaging genetics studies have thus far shown little overlap
between genome-wide significant loci associated with brain
structure and those associated with psychiatric disorders.4,7,8
One potential explanation for this discrepancy is that most
imaging-genetic studies use data collected in adolescence or
adulthood. As such they cannot address the reality that many
psychiatric disorders are unfolding processes with roots in
prenatal and early postnatal development.9,10
The prenatal–early postnatal period represents the foundational
phase of human brain development and relies on precise
spatiotemporal regulation of gene expression.11 Many genes
associated with mental illness show elevated expression in early
life,10,12 and early aberrations in neurodevelopment relevant to
psychiatric disorders can be captured via MRI as evidenced by
studies of infants at high familial risk for schizophrenia or autism
spectrum disorders (ASD).13,14 In addition, twin studies indicate
infant brain volumes are highly heritable.15 Consequently, imaging-
genetic studies in infants could provide new insights into the origins
of psychiatric disorders. Furthermore, the infant brain is highly
plastic and a promising target for therapeutic interventions. To
investigate how genetic variation impacts prenatal and early
postnatal brain development, we conducted a GWAS of global
brain tissue volumes in a unique cohort of infants who received
high-resolution MRI scans of the brain around 5 weeks of age.
MATERIALS AND METHODS
Subjects
A total of 561 infants (300 male, 261 female) between 0 and 24 weeks of
age, encompassing 295 singletons or unpaired twins, 17 sibling pairs and
232 twins (61 same-sex dizygotic (DZ) pairs, 37 same-sex monozygotic
(MZ) pairs and 18 opposite-sex DZ pairs). Overall, 63% of subjects are
European ancestry; remaining subjects are primarily African ancestry.
See Supplementary Methods and Supplementary Table 1 for additional
information.
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Image acquisition and analysis
T1- and T2-weighted scans were acquired with either a Siemens Allegra
head-only 3 T scanner (N=512) or a Siemens TIM Trio 3T scanner (N= 49)
(Siemens Medical Supplies, Erlangen, Germany). See Supplementary
Methods for acquisition parameters. ANOVA performed in 561 unrelated
subjects indicated platform (Allegra or Trio) had a significant impact on
gray matter volume and a marginal effect on intracranial volume (ICV).
Acquisition parameters within each platform did not significantly affect
brain volumes. Platform was included as a covariate in all analyses.
Automatic segmentation of brain tissue into gray matter (GM), white
matter (WM) and cerebrospinal fluid (CSF) was performed using an atlas-
based expectation-maximization segmentation algorithm using T1- and
T2-weighted images as in ref. 16. ICV represents the sum of GM, WM,
and CSF.
Genome-wide genotyping
Genotyping of single-nucleotide polymorphisms (SNPs) was carried out
using Affymetrix Axiom Genome-Wide LAT and Exome arrays. Samples
were randomized across 96-well plates. Each plate contained a common
control sample. Population stratification was assessed using principle
component analysis (PCA).17 See Supplementary Methods for additional
details. Imputation was performed with MACH-Admix18 using the 1000
Genomes Project (1000G) reference panel (phase1_release_v3.20101123).19,20
To evaluate the quality of imputed SNPs, we computed mean R2 for
varying minor allele frequency (MAF) categories and R2 cutoffs
(Supplementary Table 2).21 We retained SNPs with average R240.8 and
excluded SNPs with MAF o0.01.
Statistical methods
We investigated associations between 8 762 422 SNPs and four infant
brain volume measures (ICV, GM, WM and CSF). The first three genotypic
principal components were included as covariates as was scanner type. ICV
was a covariate for GM, WM and CSF. Additional covariates were selected
via adaptive lasso from a comprehensive set of demographic and medical
history variables (Supplementary Methods). For ICV and WM, we included
birth weight, gestational age at birth, sex and age at MRI. For GM, we
included birth weight, gestational age at birth and age at MRI. For CSF, we
included age at MRI.
To account for subject correlation among MZ and DZ twins, we applied
ACE-based linear mixed effects models.21 The ACE model not only
distinguishes correlation among MZ and DZ twins, it also includes
common environmental effect as well as random effect in the linear
mixed effect model with restricted maximum likelihood (REML) for
optimization. Association analysis was performed with two-sided likelihood
ratio tests. P-values o1.25× 10− 8 were considered genome-wide sig-
nificant (Bonferroni correction for four MRI phenotypes, which is from the
conventional GWAS threshold of 5 × 10− 8[ref. 22] divided by four). The
suggestive significance level for this correction was P= 1.25× 10− 6, which
is derived from the conventional suggestive GWAS threshold of 5 × 10− 6
[ref. 23] divided by four. The phenotypic variance explained by each SNP
was calculated as h2 = β'2var(X)/(β′2var(X)+σa
2+ σc
2+σe
2), where β′ is the
adjusted effect size of the SNP through an approximate conditional-
likelihood approach to correct for the overestimation of effect size caused




2 are the variance explained by shared genetic effect, shared environment
effect and random effect, respectively. We simulated statistical power
under a series of major genetic effect β values with varying minor allele
frequencies. We set the variance explained by genetic effect to 0.2 and the
random error variation σe
2 to 1. Sample size is sufficient to discover a
genetic effect on the order of ~ 8% with 80% power (Supplementary
Figure 1).
We ran multiple sensitivity analyses to evaluate the robustness of our
findings. We examined top SNPs in individuals with European ancestry
(based on PCA, N= 356), individuals with non-European (primarily African)
ancestry (based on PCA, N=205), individuals born after 32 weeks gestation
(N= 530), a subsample excluding offspring of mothers with a confirmed
diagnosis of schizophrenia or bipolar disorder (N=526), a subsample
excluding children who spent more than 24 hours in neonatal intensive
care (N= 427), a subsample consisting only of unrelated individuals
(N= 423), and a subsample including only the two most common image
acquisition sequences (N=538). We also ran a sensitivity analysis using the
full sample, but a reduced set of covariates. As some of our phenotypes
were moderately correlated (Supplementary Table 3), we also applied a
PCA analysis to the brain volumes and used the top three PCs as GWAS
phenotypes. Finally, to ensure the validity of our most significant GWAS
findings, we performed permutation tests for the two most significant
SNPs (Supplementary Methods).
We calculated fixation index (FST) for all linkage disequilibrium (LD)-
independent SNPs with P-values o1.25 × 10− 6 to further evaluate
potential confounding by population stratification. We checked major
and minor allele frequencies within our sample using maternal-reported
and genetic ancestry (from PCA), and cross-checked our data with allele
frequencies provided through the 1000 Genomes Project (1000G) (phase I,
version 3).25
After performing LD-pruning (--indep-pairwise 50 5 0.5: 50 bp moving
window at step of 5 bp with r2 threshold of 0.5 in PLINK, see
Supplementary Methods), we tested for enrichment of prenatally
expressed genes as described in ref. 26 using increasingly liberal P-value
thresholds. This approach down-weights noisy signal from null SNPs that
are invariably incorporated, especially at large P-value thresholds, while
capturing true, subtle signals that increase power for association.27,28 Each
SNP was assigned to the nearest gene within 2 megabases. Elevated
prenatal expression was defined as a fetal/postnatal log2 fold-change of
0.5 or greater. Analyses were performed using both the microarray-based
‘BrainCloud’ dorsolateral prefrontal cortex transcriptome29 and the RNA
sequencing-based Brainspan transcriptome of 15 brain regions.30
Using two-sided exact binomial tests (sign test) after LD-pruning, we
compared our data to two large-scale neuroimaging GWAS conducted in
older individuals: ENIGMA2,31 a primarily adult sample, and the
Philadelphia Neurodevelopmental Cohort (PNC),32 a primarily adolescent
sample (See Supplementary Methods for details). We used the—score
function in PLINK and LD-pruned genotype data from our neonate cohort
to generate polygenic scores for ICV, GM and WM at nine different P-value
thresholds (ambiguous SNPs were not included). These ‘neonatal scores’
were used to predict the equivalent phenotype in the PNC cohort
(covarying for age, sex and first three ancestry PCs). In a similar manner, we
generated polygenic scores for ICV, GM and WM using the PNC cohort and
used these ‘adolescent scores’ to predict the equivalent phenotype in
neonates. Covariates were the same as in univariate neonate analyses.
Finally, we generated polygenic scores for ICV using ENIGMA2 data. Note
that data on GM and WM is not available for ENIGMA2. This ‘adult ICV
score’ was used to predict ICV in the neonate cohort and PNC cohorts. Only
summary-level GWAS data was available for ENIGMA2; consequently adult
ICV never served as a dependent variable. The same procedure was used
to generate genetic predisposition scores for schizophrenia33 and ASD.34
Resulting risk scores were used as predictors for neonatal brain volumes.
Gene set-enrichment analysis (GSEA) was performed on each brain
volume GWAS with MAGMA.35 We tested candidate pathways implicated
in psychiatric disorders including glutamatergic postsynaptic proteins
comprising activity-regulated cytoskeleton-associated protein (ARC)36–38
and N-methyl-D-aspartate receptor (NMDAR) complexes,38,39 genes whose
mRNAs bind to fragile X mental retardation protein (FMRP),36,37,39,40,41
calcium channels34,40,42 and genes involved in histone methylation.43 We
focused on pathways supported by convergent evidence from genome-
wide screens for common and exonic variation and CNVs. Given our
univariate results, we also tested genes with REST binding sites44 and Rbfox
targets. For the latter analysis, we used genes with RBFOX2 count 44 or
summed RBFOX1 and RBFOX3 412.45
PennCNV and Partek Genomics Suite 6.6 were used for CNV calling from
signal intensity files of the Affymetrix Axiom Genotype array.46 Included
CNVs had SNP coverage 415, length 4100 kb, and for PennCNV,
confidence score ⩾ 10. We excluded CNVs with 450% overlap with
common CNVs (freq 41% in EUR population47 or our population) or
regions of known rearrangement (chr14:105573485–107197774 and
chr22:22473003–23188329). CNVs occuring in both PennCNV and Partek
were considered validated CNVs. See Supplementary Appendix 1 for
details. Linear mixed effects models were used to test whether CNV burden
(number of CNV-affected genes per subject) predicted ICV, GM, WM and
CSF. Covariates were the same as in univariate analyses. Finally, we
determined whether any one in the sample carried a rare CNV that
overlapped with known neuropsychiatric CNVs (Supplementary Table 4).
Experiments were undertaken with the understanding and written
consent of each subject’s mother or father, with the approval of the
Institutional Review Board of the University of North Carolina (UNC) School
of Medicine.
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Code availability
Computer code used to generate study results can be found at http://
www.bios.unc.edu/research/genomic_software/CorrMeta/ace/.
RESULTS
Table 1 displays all LD-independent SNPs with P-values
o1.25 × 10− 6. Quantile–quantile plots are displayed in
Supplementary Figure 2. Locus zoom plots are displayed in
Supplementary Figures 3–6. Lambda is 1.01 for ICV and WM, 1.00
for GM and 0.98 for CSF. Lambda-1000 is 1.01 for ICV, WM and GM,
and 0.96 for CSF. An intronic SNP in IGFBP7 (rs114518130)
achieved genome-wide significance for GM (P= 4.15 × 10− 10,
Figure 1 and Supplementary Figure 5). An intronic SNP in WWOX
(rs10514437) fell just short of genome-wide significance for WM
(P= 1.56 × 10− 8, Figure 1 and Supplementary Figures 4 and 7).
Additional loci nearing genome-wide significance were located
near (within 500 kb) transcriptional regulators expressed in
developing brain, psychiatric GWAS associations, and genes
involved in neurotransmitter signaling and neural development
(Supplementary Table 5). LD-independent SNPs with P-values
o1.25 × 10− 6 were associated with absolute percent differences
of 0.85–9.54% in volume per risk allele, explaining 0.27–6.52% of
the phenotypic variance (after correction for ‘winner’s curse’).
Effect sizes in primary analyses were highly similar to effect sizes in
sensitivity analyses (Supplementary Table 6) with the exception of
rs113668862 (association with CSF, P= 5.9 × 10− 7), which showed
no effect on CSF in non-European populations. Similar genes
emerged when using the top three PCs from a PCA analysis of the
brain volumes as GWAS phenotypes (Supplementary Table 7).
Permutation testing yielded an empirical P-value of 8 × 10− 8 for
rs10514437’s association with WM and an empirical P-value of
1 × 10− 8 for rs114518130’s association with GM. Low empirical P-
values suggest these findings are reliable and robust.
FST values40.05, indicating potential confounding by ancestry,
were observed for rs9831671 (association with ICV,
P= 9.49 × 10− 7), rs7786147 (association with GM, P= 1.15 × 10− 7),
rs2565117 (association with GM, P= 2.88 × 10− 7) and rs113668862
(association with CSF, P= 5.9 × 10− 7). Although FST values were
below 0.05 for our top hits in IGFBP7 and WWOX, we note that the
minor (A) allele for the IGFBP7 SNP is very rare in populations of
European ancestry (Supplementary Table 8). We were unable to
run sensitivity analysis in individuals of European ancestry as the
minor allele did not occur in this group.
Three genes, TOX3, FRG1 and c7orf11 (MPLKIP) show elevated
prenatal expression across multiple brain regions (Supplementary
Appendix 2; Supplementary Table 9). KLF13, WWOX, SLC13A3,
HTR1B, MYOM1, ZMAT4, CNDP1, CACNB2 and SEC14L5 show a
strong increase in expression from prenatal to postnatal life. EYA2,
USP44, OPA1, SLC35F4, CTH, RBFOX1 and METTL4 show elevated
prenatal expression in a small subset of brain regions. Examination
of exon level expression data from Brainspan suggests METTL4,
C16orf62 and RBFOX1 have specific isoforms with differentially
regulated expression across the lifespan (Supplementary
Appendix 3). Tests for enrichment of prenatally expressed genes
were significant at multiple thresholds across multiple brain
regions (Figure 2).
Comparing our neonate cohort to the adolescent cohort, sign
tests for WM were significant at thresholds of Po0.001, Po0.01
and Po0.1 (Figure 3). Percent overlap is small with 53.8, 51.2 and
50.6% of SNPs showing the same direction of effect versus 50%
expected by chance. Comparing our neonate cohort to the adult
cohort, the sign test for ICV is significant at the threshold of
Po0.1 with 50.40% overlap. Comparing the adolescent cohort to
Table 1. LD-independent SNPs with P-values smaller than 1.25× 10− 6
Tissue
volume
Chr Best SNP A1 A2 MAF Effect size Likelihood ratio P-value Variance
explained
Diff./allele Closest protein coding gene
(±500 kb)
ICV 15 rs8030297 T G 0.07 − 32 231 28.46 9.56E− 08 2.47 − 6.73 KLF13
20 rs4809613 A G 0.17 − 19 053 24.38 7.91E− 07 0.36 − 3.98 EYA2
3 rs9831671 T G 0.27 20 450 24.03 9.49E− 07 0.43 4.27 LMCD1
WM 16 rs10514437 G A 0.03 − 6617 31.97 1.56E− 08 4.14 − 3.76 WWOX
20 rs117068934 G A 0.03 − 5988 26.34 2.86E− 07 1.01 − 3.41 SLC13A3
6 rs9361254 G T 0.13 − 3106 24.10 9.16E− 07 0.31 − 1.77 MEI4a, HTR1B
18 rs138549714 G GT 0.07 − 3608 23.96 9.85E− 07 0.29 − 2.05 MYOM1
12 rs11834561 G A 0.38 2071 23.92 1.00E− 06 0.29 1.18 USP44
21 rs200193477 A AT 0.26 3577 23.66 1.15E− 06 0.27 2.03 —
GM 4 rs114518130b G A 0.01 14 973 39.04 4.15E− 10 6.52 6.13 IGFBP7
7 rs7786147 C T 0.11 − 4135 28.10 1.15E− 07 2.27 − 1.69 MPLKIPc
3 rs200355458 C CG 0.09 4657 27.74 1.39E− 07 1.86 1.91 OPA1
8 rs2565117 C A 0.01 − 10 939 26.33 2.88E− 07 1.12 − 4.48 ZMAT4
18 rs138087875 A AC 0.06 4789 25.78 3.83E− 07 0.60 1.96 CNDP1
16 rs12919005 C G 0.03 6973 25.55 4.31E− 07 0.51 2.85 TOX3
9 rs77196186 C T 0.05 − 4970 24.77 6.45E− 07 0.40 − 2.03 CAAP1
16 rs9889138 G A 0.07 4482 24.39 7.86E− 07 0.34 1.83 C16orf62
14 rs1092055 T C 0.45 2142 24.28 8.32E− 07 0.34 0.88 SLC35F4
10 rs11012877 G A 0.11 3683 24.23 8.54E− 07 0.33 1.51 CACNB2
1 rs2992041 C T 0.43 2516 24.05 9.37E− 07 0.32 1.03 CTH
16 rs7206373 G C 0.46 2084 23.77 1.09E− 06 0.29 0.85 SEC14L5
CSF 16 rs7195044 C G 0.09 5619 26.55 2.56E− 07 1.33 9.54 RBFOX1
17 rs11867179 C G 0.24 3042 25.43 4.6E− 07 0.53 5.17 TBX4
4 rs113668862 C T 0.08 − 4951 24.95 5.9E− 07 0.43 − 8.41 FRG1
18 rs11875537 T G 0.44 2559 24.35 8.05E− 07 0.37 4.35 METTL4
Abbreviations: CSF, cerebrospinal fluid; GM, gray matter; ICV, intracranial volume; LD, linkage disequalibrium; MAF, minor allele frequency; SNP,
single-nucleotide polymorphism; WM, white matter. aProvisional or inferred status in RefSeq (next closest protein coding gene within 500 kb is also listed).
bGenome-wide significant (Po1.25 × 10− 8), Bonferroni correction of 5 × 10−8 for four phenotypes. cAlso known as c7orf11. Note that all SNPs are imputed with
the exception of rs10514437; see Supplementary Figure 2 for a genotyping cluster plot of rs10514437. A1 is the effective allele and A2 is the reference allele.
Diff./allele is the ratio of effect size over mean brain volume. We define LD-independent SNPs as those with low LD (r2o0.1) to a more significantly associated
SNP within a 500 kb window.
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Figure 1. Common genetic variants associated with infant brain volumes. Manhattan plots colored with a scheme that matches the
corresponding tissue volume (middle) are shown (yellow is white matter (WM); green is gray matter (GM); blue is cerebrospinal fluid (CSF)).
Genome-wide significance is shown for the threshold of P= 1.25 × 10− 8 (gray dotted line). The green line indicates the threshold of
P= 1.25 × 10− 6. The most significant single-nucleotide polymorphism (SNP) for each phenotype is labeled.
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the adult cohort, the sign test for ICV is significant at the threshold
of Po0.1 with 50.80% overlap.
Neonatal polygenic scores for WM showed positive associations
with adolescent WM at thresholds between Po0.01 and Po0.5
(Figure 4). Adolescent WM scores showed positive associations
with neonatal WM at 7 of 9 P-value thresholds, and adolescent GM
scores showed a positive association with neonatal GM at the
threshold of Po0.1. Adult polygenic scores for ICV did not predict
neonatal ICV, but did predict adolescent ICV at 8 of 9 P-value
thresholds. When comparing across ages, polygenic scores
explained between 0.4 and 1.6% of variance after adjusting for
covariates. Scatterplots of significant relationships can be found in
Figure 2. Enrichment of prenatally expressed genes at multiple P-value thresholds. After LD-pruning, each single-nucleotide polymorphism
(SNP) was assigned to the nearest gene within 2 megabases. Elevated prenatal expression was defined as a fetal/postnatal log2 fold-change
threshold of 0.5. Analyses were performed using both the microarray-based ‘BrainCloud’ dorsolateral prefrontal cortex (DLPFC)
transcriptome31 and the RNA sequencing-based Brainspan transcriptome of 15 different brain regions.32 Left panels show − log10 P-values.
Orange line represents the threshold for statistical significance. Right panels show percentage of genes with elevated prenatal expression. (a)
intracranial volume (ICV). (b) white matter (WM). (c) gray matter (GM). (d) CSF.
Common variants influencing infant brain volumes
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Supplementary Figure 8. To put these numbers in context, neonatal
polygenic scores explain between 74 and 93% of variance in
neonatal brain volumes after adjusting for covariates and adolescent
polygenic scores explain between 67 and 93% of variance in
adolescent brain volumes after adjusting for covariates.
Supplementary Table 10 lists all LD-independent SNPs with P-
values o1.25 × 10− 6 in the neonate and compares them to
equivalent SNPs and phenotypes in PNC and ENIGMA2. The SNP
tagging EYA2 is nominally significant in ENIGMA2 (P= 0.048) with
the same direction of effect. No other overlapping SNPs are
significant in PNC or ENIGMA2, but some of our top hits are not
represented in PNC data as they failed imputation quality control.
Previously published genome-wide significant hits for ICV8,48,49 in
adults did not predict ICV in infants (Supplementary Table 11),
although we were unable to examine rs9303535 as it was not in
the 1000G reference database and hence not imputed. No suitable
proxy SNPs were available.
Genetic predisposition scores for schizophrenia and ASD did
not predict neonatal brain volumes (Supplementary Figure 9).
Regarding GSEA, Rbfox targets showed a nominally significant
association with CSF, but no gene sets achieved significance after
correction for multiple comparisons (Supplementary Table 12).
Figure 3. Sign tests suggest minimal overlap between common variants impacting brain volumes in neonates, adolescents and adults. (a) Left
panel shows –log10 P-values for two-sided exact binomial tests comparing single-nucleotide polymorphisms (SNPs) impacting intracranial
volume (ICV) and ICV-adjusted white matter (WM) and gray matter (GM) in neonates to the same SNPs in adolescents (PNC). Right panel
shows percent overlap. Tests for ICV-adjusted WM are significant (P= 0.02, 0.04 and 0.01) at the thresholds of Po0.001, Po0.01, and Po0.1,
respectively. (b) Left panel shows –log10 P-values for two-sided exact binomial tests comparing SNPs impacting ICV in neonates to the same
SNPs in adults (ENIGMA2). Right panel shows percent overlap. Test is significant at the threshold of Po0.1 (P= 0.02). (c) Left panel shows –
log10 P-values for two-sided exact binomial tests comparing SNPs impacting ICV in adolescents (PNC) to the same SNPs in adults (ENIGMA2).
Right panel shows percent overlap. Test is significant at the threshold of Po0.1 (P= 0.001). * indicates significance.
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CNV burden was not significantly associated with any of the
neuroimaging traits examined (Supplementary Figure 10). Four
individuals carried a rare CNV, which overlapped with a known
neuropsychiatric CNV. Percent overlap ranged from 0.27 to
96.29%. All CNVs affected at least one gene also present in the
known neuropsychiatric CNV. Two of these children had a history
of psychiatric illness in one or both parents (attention deficit
disorder or anxiety disorder). Review of medical records indicated
Figure 4. Polygenic scores for neonatal, adolescent and adult brain volumes suggest genetic determinants of global brain volumes are highly
distinct at different ages. (a) Left panel shows –log10 P-values for the association between neonatal polygenic scores for intracranial volume
(ICV), ICV-adjusted white matter (WM), and ICV-adjusted gray matter (GM) and the matching phenotype in adolescents (PNC). Middle panel
shows the effect size and direction of effect (Beta). Right panel shows the r2 value (percentage of variance explained after adjusting for
covariates). (b) Left panel shows –log10 P-values for the association between adolescent polygenic scores for ICV, ICV-adjusted WM, and ICV-
adjusted GM and the matching phenotype in this neonatal cohort. Middle panel shows the effect size and direction of effect (Beta). Right panel
shows the r2 value (percentage of variance explained after adjusting for covariates). (c) Left panel shows –log10 P-values for the association
between adult (ENIGMA2) polygenic scores for ICV and ICV in this neonatal cohort. Middle panel shows the effect size and direction of effect
(Beta). Right panel shows the r2 value (percentage of variance explained after adjusting for covariates). (d) Left panel shows –log10 P-values for
the association between adult (ENIGMA2) polygenic scores for ICV and ICV in adolescents (PNC). Middle panel shows the effect size and
direction of effect (Beta). Right panel shows the r2 value (percentage of variance explained after adjusting for covariates).* indicates significance.
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that one child had delayed speech and fine motor skills at 2 years
of age. Long-term follow-up data was not available. Examination
of individual value plots suggested these individuals had
brain volumes in the normal range at this age (Supplementary
Figure 11).
DISCUSSION
The prenatal and early postnatal period represents a critical
window in brain development with long-term implications for
cognition50,51 and psychiatric risk.9,10 In this first GWAS of infant
neuroimaging phenotypes, an intronic SNP in IGFBP7
(rs114518130) achieved genome-wide significance for GM. An
intronic SNP in WWOX (rs10514437) fell just short of genome-wide
significance for WM. Although IGFBP7 has been implicated in
learning and memory,52 it is perhaps even more intriguing that
this SNP is within 100 kb of REST, which encodes a master
negative regulator of neurogenesis.44 Experimental manipulation
of the REST/NRSF-SWI/SNF chromatin remodeling complex alters
expression of several GWAS-supported schizophrenia genes.53
However, GSEA analysis of REST targets did not reach significance,
somewhat diminishing the case that REST is the causal element in
this association. Mutations in WWOX are associated with brain
phenotypes including autosomal recessive spinocerebellar ataxia-
12 (SCAR12; MIM #614322), epilepsy, mental retardation and
microcephaly. MRI studies are limited, but hypomyelination,
hypoplasia of the corpus callosum and posterior white matter
hyperintensities have been reported. In adult human brains, levels
of the protein encoded by WWOX (WOX1) are high in neuronal
axons and nerve bundles such as corpus callosum and striatal
fascicles,54 consistent with our observed association with WM.
Many top associations tag transcriptional regulators expressed
in developing brain (KLF13, LMCD1, TOX3 and TBX4), though none
are known eQTLs. Other genes with strong biological plausibility
include CACNB2, a calcium channel subunit which has emerged in
schizophrenia GWAS,33 HTR1B, which encodes the 5-
hydroxytryptamine (serotonin) receptor 1B, and RBFOX1, an RNA
splicing factor, which regulates expression of large genetic
networks during early neuronal development.55 Most of these
genes show a strong increase in expression from the prenatal to
the postnatal period, whereas TOX3 shows elevated prenatal
expression. Examination of exon level expression data suggests
the first several exons of RBFOX1 show elevated prenatal
expression. When examining more permissive P-value thresholds,
there was evidence of significant prenatal expression enrichment
for all phenotypes examined.
We compared our results to two large-scale neuroimaging
GWAS, one focused on adolescents (PNC)32 and one on adults
(ENIGMA2).31 These comparisons do not represent a conventional
replication sample. Instead, they represent a test of whether there
are shared genetic determinants of global brain volumes at
differing ages. Sign tests and polygenic score analyses suggest
genetic variants influencing neonatal WM have detectable effects
in adolescence. Polygenic score analyses suggest genetic variants
influencing ICV in adults have detectable effects in adolescence.
However, percent overlap in sign tests was minimal and the
percent of variance explained by polygenic scores was small. The
overall pattern of results suggests genetic determinants of global
brain volumes are highly distinct at different ages. Variants
associated with neonatal brain volumes are likely located in genes
involved with foundational prenatal processes including neuro-
genesis, neuronal migration and differentiation, programmed cell
death, dendritogenesis and axonogenesis.56 Variants associated
with adolescent brain volumes are likely located in genes
involved in postnatal neurodevelopmental processes including
synaptogenesis during early childhood and synaptic/dendritic
pruning during early adolescence. Variants associated with adult
brain volumes likely represent synaptic/dendritic pruning in late
adolescence and perhaps neurodegenerative events associated
with aging.56
Genetic predisposition scores for schizophrenia and ASD did
not predict global brain volumes in neonates. Results are similar to
a recent study, which found no evidence of genetic overlap
between schizophrenia risk and ICV in adults.7 To our knowledge,
this is the first study to apply a similar approach for ASD risk. In
addition, although rare genic CNVs are increased in ASD57 and
schizophrenia,58 CNV burden did not predict global brain volumes
in neonates. Null findings should be considered in light of several
qualifiers. First, genetic variants associated with disease may
influence neurodevelopmental processes occurring at a resolution
not captured by MRI. Second, other neuroimaging phenotypes
may be more relevant to ASD and schizophrenia (for example,
cortical thickness and surface area, ventricular volume, diffusion
tensor imaging or functional activity/connectivity).13,59–63 Third,
longitudinal change in neuroimaging phenotypes may be more
relevant to ASD and schizophrenia than cross-sectional
measures.64 Finally, although many psychiatric risk genes show
elevated expression in early life10,12 differences in global brain
volumes may not arise until later in life. Regarding ASD, 6-month-
old infants at high familial risk do not have larger brain volumes
than low risk infants, despite reports of generalized enlargement
in older children with ASD.65 Regarding schizophrenia, neonates at
high familial risk do have larger GM volume than controls, but this
affect is restricted to males.14 Future studies with larger samples
should address how genetic predisposition and CNV burden
influence neurodevelopmental trajectories across infancy and
childhood, as well as possible interactions with sex. Larger
samples would also allow stable estimates of SNP-sense herit-
ability to be calculated.
In conclusion, we have shown that common genetic variation
influences infant brain volumes. Several individual loci identified
in this study have clear relevance to intellectual disability and
mental illness, although genetic predisposition scores for schizo-
phrenia and ASD did not predict variation in our sample. To our
knowledge, this is the first study of its kind, consequently
independent replication is critical. This is particularly true for the
intronic SNP in IGFBP7, which has a low minor allele frequency,
was imputed, and was not present in the largest racial/ethnic
group in the study. Nevertheless, the current results suggest this
area of research will be fruitful. Ultimately, by identifying genes
contributing to developmental phenotypes, it may be possible to
develop treatments that normalize adverse trajectories, prevent-
ing the onset of psychiatric disorders or reducing their severity.
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